Cite

HARVARD Citation

    Pope, J. et al. (n.d.). THU0169 Persistence of Tofacitinib in The Treatment of Rheumatoid Arthritis in Open-Label, Long-Term Extension Studies up To 7 Years. Annals of the rheumatic diseases. p. 245. [Online]. 
  
Back to record